Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular Profiling in Non-Squamous Non-Small Cell Lung Carcinoma: Towards a Switch to Next-Generation Sequencing Reflex Testing
Nina Pujol, Simon Heeke, Christophe Bontoux, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 10, pp. 1684-1684
Open Access | Times Cited: 11

Showing 11 citing articles:

Current challenges and practical aspects of molecular pathology for non-small cell lung cancers
Paul Hofman, Sabina Berezowska, Daniel Kazdal, et al.
Virchows Archiv (2023) Vol. 484, Iss. 2, pp. 233-246
Open Access | Times Cited: 18
Real-world EGFR testing practices for non-small-cell lung cancer by thoracic pathology laboratories across Europe
Paul Hofman, Fiorella Calabrese, Izidor Kern, et al.
ESMO Open (2023) Vol. 8, Iss. 5, pp. 101628-101628
Open Access | Times Cited: 16
Lung Cancer Therapy: The Role of Personalized Medicine
Raquel Ramos, Conceição Souto Moura, Mariana Fernandes Costa, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 725-725
Open Access
Redefining resectability: Bridging perspectives in stage III NSCLC management
Luca Bertolaccini, Monica Casiraghi, Antonio Mazzella, et al.
Lung Cancer (2025), pp. 108509-108509
Closed Access
Matched tissue and liquid biopsies for advanced non-small cell lung cancer patients A potentially indispensable complementary approach
Paul Hofman
Translational Oncology (2023) Vol. 35, pp. 101735-101735
Open Access | Times Cited: 7
Liquid biopsy in non-small cell lung cancer: a meta-analysis of state-of-the-art and future perspectives
Sara Franzi, Gabriele Seresini, Paola Borella, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 7
Actionable mutational profiling in solid tumors using hybrid‐capture‐based next‐generation sequencing in a real‐world setting in Spain
Sandra Zazo, Sandra Pérez‐Buira, Nerea Carvajal, et al.
Cancer Medicine (2024) Vol. 13, Iss. 3
Open Access | Times Cited: 2
Enhancing Lung Cancer Care in Portugal: Bridging Gaps for Improved Patient Outcomes
Raquel Ramos, Conceição Souto Moura, Mariana Fernandes Costa, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 5, pp. 446-446
Open Access | Times Cited: 2
The Detailed Analysis of Polish Patients with Non-Small Cell Lung Cancer Through Insights from Molecular Testing (POL-MOL Study)
Dariusz M. Kowalski, Magdalena Zaborowska-Szmit, Maciej Bryl, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11354-11354
Open Access | Times Cited: 2
Editorial: Molecular genetic testing and emerging targeted therapies for non-small cell lung cancer
Carlos Gil Ferreira, Marina Xavier Reis, Gilson Gabriel Viana Veloso
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5
A Real-World Experience from a Single Center (LPCE, Nice, France) Highlights the Urgent Need to Abandon Immunohistochemistry for ROS1 Rearrangement Screening of Advanced Non-Squamous Non-Small Cell Lung Cancer
Véronique Hofman, Samantha Goffinet, Christophe Bontoux, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 5, pp. 810-810
Open Access | Times Cited: 2
Advancing Cancer Care in Colombia: Results of the First In Situ Implementation of Comprehensive Genomic Profiling
Juan Javier López-Rivera, Paula Rueda‐Gaitán, Laura Camila Rios Pinto, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 9, pp. 975-975
Open Access
Page 1

Scroll to top